5/23/2024

Insulin Lispro Injection (Humalog)

Products Affected - Description

- Humalog solution for injection, Lilly USA, LLC, 100 unit/mL, 3 mL vial, NDC 00002-7533-01 - discontinued
- Humalog solution for injection, Lilly USA, LLC, 100 unit/mL, 3 mL vial, NDC 00002-7510-17 - discontinued

Reason for the Shortage

- Lilly has Humalog and insulin lispro products available. Lilly discontinued Humalog 3 mL vials in early-2024.
- Sanofi has Admelog vials and Solostar Pens available.

Available Products

- Humalog solution for injection, Lilly USA, LLC, 100 unit/mL, 10 mL vial, NDC 00002-7510-01
- Humalog Jr. KwikPen solution for injection, Lilly USA, LLC, 100 unit/mL, 3 mL pen injector, 5 count, NDC 00002-7714-59
- Humalog KwikPen solution for injection, Lilly USA, LLC, 100 unit/mL, 3 mL pen injector, 5 count, NDC 00002-8799-59
- Insulin lispro Jr. KwikPen solution for injection, Lilly USA, LLC, 100 unit/mL, 3 mL pen injector, 5 count, NDC 00002-7752-05
- Insulin lispro KwikPen solution for injection, Lilly USA, LLC, 100 unit/mL, 3 mL pen injector, 5 count, NDC 00002-8222-59
- Insulin lispro solution for injection, Lilly USA, LLC, 100 unit/mL, 10 mL vial, NDC 00002-7737-01

Updated

Updated May 23, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 29, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.